Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
HCPCS Code

HCPCS code J7332 – Triluron (sodium hyaluronate) injection


Code Definition

J7332 is the HCPCS Level II code for hyaluronan or derivative, Triluron, for intra-articular injection, 1 mg. It covers one product, Triluron, and one unit equals 1 mg.

A full Triluron syringe holds 20 mg in 2 mL, so you bill 20 units at each of three weekly visits. Other hyaluronan products bill their own codes, such as SynoJoynt (J7331) or Euflexxa (J7323).

Level
Level II
Category
J0000-J9999 Drugs administered other than oral method
Status
Active, added October 1, 2019
Billable
No
Code also known as
Triluron injection, sodium hyaluronate knee injection, hyaluronic acid knee injection, viscosupplementation injection
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

HCPCS Code J7332 bills one product, Triluron, a sodium hyaluronate knee injection, at 1 mg per unit

A full Triluron syringe holds 20 mg in 2 mL, so each injection bills 20 units of J7332

A Triluron course is three weekly injections, billed one date of service at a time, never 60 units on one line

Every other hyaluronan product has its own J-code, and a product with no code of its own bills an unlisted code such as J3490

Medicare pays J7332 at ASP plus 6%, and that payment limit is the figure CMS updates each quarter

HCPCS code J7332 bills Triluron by the milligram

HCPCS Code J7332 is the Level II code for Triluron, an intra-articular sodium hyaluronate injection for knee osteoarthritis. The official long descriptor reads “Hyaluronan or derivative, Triluron, for intra-articular injection, 1 mg.” NGS’s Medicare billing article names J7332 as Triluron’s code for dates of service from October 1, 2019.

The code reports the drug only. The injection bills separately, usually with CPT 20610 or 20611. CMS created the code in the October 2019 quarterly update to the HCPCS Level II code set, after the FDA approved Triluron in March 2019.

AttributeDetail
CodeJ7332
Long descriptorHyaluronan or derivative, Triluron, for intra-articular injection, 1 mg
Short descriptorInj., triluron, 1 mg
ProductTriluron (sodium hyaluronate), Fidia Pharma USA
Billing unit1 mg = 1 unit
Supplied as20 mg/2 mL single-dose syringe, NDC 89122-0879-xx
Units per full injection20
Treatment courseThree injections, one week apart
IndicationKnee osteoarthritis
Companion CPT20610 (major joint, without ultrasound guidance) or 20611 (with ultrasound guidance)
Medicare payment basisASP plus 6%, with the payment limit updated quarterly
Code addedOctober 1, 2019

What J7332 covers, and where it stops

J7332 names one product in its descriptor, and that product is Triluron. Every other hyaluronan product bills under the code CMS assigned to that product, not J7332.

A hyaluronan product with no code of its own bills an unlisted drug code such as J3490. Put the product name and NDC on the claim, and check the payer’s instructions for unlisted codes first.

  • Billed with J7332: Triluron 20 mg/2 mL, injected into the knee joint.
  • Covered indication: pain from knee osteoarthritis, the indication in Triluron’s FDA approval and in Medicare contractor billing articles.
  • Not J7332: any other hyaluronan brand, even at the same 20 mg dose. Euflexxa bills J7323 and SynoJoynt bills J7331.
  • Not J7332: hip, shoulder, or other joint injections, which fall outside Triluron’s knee-only approval and most payer policies.
  • Not J7332: hyaluronic acid dermal fillers or surgical aids, which are not intra-articular drugs.

The descriptor and the product behind J7332 do not change from quarter to quarter. The figure CMS revises every quarter is the ASP payment limit, covered in the pricing section below.

Count milligrams to get the J7332 units right

One unit of J7332 equals 1 mg of Triluron. A full syringe holds 20 mg, so a standard injection bills 20 units.

Bill each injection on its own date of service. Three weekly injections produce three claim lines of 20 units each, never one line of 60 units.

Treating both knees on the same day doubles the drug, so report 40 units. Follow your Medicare contractor’s billing article for the bilateral convention, such as RT and LT lines.

ScenarioJ7332 unitsHow to report it
One knee, full syringe20One line on the date of service, with JZ on Medicare claims
Both knees, same day40Per the payer’s bilateral rule, such as RT and LT lines of 20 units each
Full three-injection course, one knee20 per visitThree dates of service, three lines, never 60 units on one line
Part of a syringe discardedAdministered mg, plus discarded mgAdministered amount on one line, discarded amount on a second line with JW

Wastage modifiers JW and JZ

Triluron comes in a single-dose syringe, so Medicare’s drug wastage rules apply. Since July 1, 2023, Medicare claims need JZ when nothing is discarded from a single-dose container.

If part of the syringe is discarded, bill the administered amount on one line. Bill the discarded amount on a second line with JW, and record that amount in the chart.

Pair J7332 with CPT 20610 and a precise knee diagnosis

CPT 20610 reports aspiration or injection of a major joint without ultrasound guidance. CPT 20611 adds ultrasound guidance with a permanent recorded image, so save the image to the record.

Bill the drug and the administration on separate claim lines. The diagnosis should name knee osteoarthritis with laterality, because unspecified codes invite questions on review.

Medicare contractor billing articles list covered codes from the M17 category. The codes below are common examples, so check the full covered list for your jurisdiction before you submit.

ICD-10-CM codeDescriptionWhen it fits
M17.0Bilateral primary osteoarthritis of kneePrimary OA in both knees
M17.11Unilateral primary osteoarthritis, right kneePrimary OA, right knee injected
M17.12Unilateral primary osteoarthritis, left kneePrimary OA, left knee injected
M17.31Unilateral post-traumatic osteoarthritis, right kneeOA after a right knee injury
M17.32Unilateral post-traumatic osteoarthritis, left kneeOA after a left knee injury

Per mg or per dose? Where J7332 sits among hyaluronan codes

Each hyaluronan code names its own product or products in the descriptor. Some bill per milligram and some per dose, so the units on one injection run from 1 to 168. That split is where most unit errors start.

Bar chart of units billed per hyaluronan knee injection
Triluron’s 20 units sit mid-range, and SynoJoynt bills the same 20, so a swapped code slips past a units check. Figures come from the HCPCS descriptors and product dosing covered in this article.
HCPCS codeProductBilling unitTypical courseUnits per injection
J7318Durolane1 mg1 injection of 60 mg60
J7320GenVisc 8501 mg5 weekly injections of 25 mg25
J7321Hyalgan, Supartz, Supartz FX, or Visco-3Per dose3 to 5 weekly injections, by product1
J7322Hymovis1 mg2 weekly injections of 24 mg24
J7323EuflexxaPer dose3 weekly injections1
J7324OrthoviscPer dose3 or 4 weekly injections1
J7325Synvisc or Synvisc-One1 mg3 injections of 16 mg, or 1 of 48 mg16 or 48
J7326Gel-OnePer dose1 injection1
J7327MonoviscPer dose1 injection1
J7328Gelsyn-30.1 mg3 weekly injections of 16.8 mg168
J7329TriVisc1 mg3 weekly injections of 25 mg25
J7331SynoJoynt1 mg3 weekly injections of 20 mg20
J7332Triluron1 mg3 weekly injections of 20 mg20

J7332 and J7331 bill the same 20 units for the same 20 mg dose. A swapped code is easy to miss on review, so match the product’s NDC to its code before submission.

Older charge masters may still carry J7333 for Visco-3. Current payer policies list Visco-3 under J7321, billed per dose, so audit any leftover entry.

Medicare pays J7332 at ASP plus 6%

Medicare Part B pays J7332 at the average sales price plus 6%, per unit. CMS publishes the per-unit payment limit in the quarterly ASP pricing files.

Multiply the current per-unit limit by 20 to price one syringe. Medicare pays 80% after the Part B deductible, and the patient owes 20% coinsurance.

The physician fee schedule search does not price J7332. It prices the administration code, 20610 or 20611, which pays differently in an office and in a facility.

In an office, the practice buys the drug and bills J7332 itself. In a hospital outpatient department, the hospital bills the drug under the outpatient payment system. The physician then bills only the administration, at the facility rate.

Pro Tip

Price J7332 from the ASP file, not from memory. Pull the current quarter’s per-unit limit, multiply by 20 for one syringe, and compare it with your acquisition cost before you schedule the series.

Medicare coverage and prior authorization for J7332

Traditional Medicare covers hyaluronan knee injections under the Part B drug benefit. No national coverage determination applies, so each Medicare Administrative Contractor publishes its own billing and coding article.

Examples include Palmetto GBA article A59030, NGS article A52420, and WPS article A56157. These articles set the covered diagnoses and the rules for a repeat series.

A repeat series commonly needs six months since the last one and documented improvement from it. Read the article for your jurisdiction before you schedule a second course.

Traditional Medicare does not require prior authorization for J7332. Medicare Advantage plans and most commercial payers do, and confirming it before the first injection is part of a clean claim.

Step therapy sits at the core of most authorization criteria. Payers want dated evidence that conservative care failed first. That usually means oral analgesics or NSAIDs, physical therapy, and at least one corticosteroid injection.

  • Traditional Medicare: no prior authorization, but the chart must document medical necessity.
  • Medicare Advantage: authorization is usually required, and a missing one is a common denial that is hard to overturn.
  • Commercial insurers: most require authorization with step therapy records. Some prefer specific hyaluronan brands, so confirm Triluron is on the plan’s list.
  • Authorization checklist: ICD-10-CM code with laterality, imaging report, conservative treatment history, the NDC, and the planned injection dates.

Documentation that holds up when a payer asks

Auditors expect each injection note to stand alone. A note reading “patient returned for second injection” fails if it does not link back to the diagnosis, imaging, and failed conservative care.

Build a template that captures every element at each visit. Good medical billing compliance also means reviewing that template against your contractor’s current billing article each year.

Documentation elementWhat auditors look for
DiagnosisAn M17 knee osteoarthritis code with laterality that matches the billed claim
Imaging reportX-ray or MRI findings that support knee osteoarthritis, such as joint-space narrowing
Conservative careDated entries for analgesics, physical therapy, and corticosteroid injection, with the length of each trial
Drug administeredTriluron, NDC 89122-0879-xx, lot number, dose in mg, and which knee was injected
WastageJZ when the full 20 mg was given, or the discarded amount in mg when JW is billed
ResponsePain and function scores at follow-up, which support any repeat series

Common mistakes that get J7332 claims denied

J7332 denials fall into a handful of patterns that repeat across claims. Good denial management workflows trace each one to its root cause rather than appealing claims one at a time.

Denial reasonRoot causeCorrective action
Wrong J-code for the productTriluron billed as J7331 or another sibling, or the NDC does not match the codeMap the Triluron NDC to J7332 in the charge master and check it at charge entry
Triluron billed as unlistedJ3490 used even though Triluron has its own codeBill J7332, which has named Triluron since October 2019
Incorrect unit countOne unit per injection, as on a per-dose code, or 60 units on one lineBill 20 units per syringe, on each date of service
Missing prior authorizationInjection given without Medicare Advantage or commercial approvalVerify the authorization number before the first injection
Missing conservative care recordsNo dated record of failed analgesics, therapy, or steroid injectionUse a documentation template that captures step therapy before ordering
Repeat series too soonSecond course billed inside the contractor’s waiting periodTrack series start dates per knee and flag the next eligible date
Missing JZ or JWWastage modifier left off a Medicare drug lineAdd JZ for a full dose, or JW on a separate line for discarded drug

When a J7332 claim is denied under medical billing denial codes for medical necessity, the appeal needs the full clinical record. Send imaging, conservative care history, and the treating provider’s attestation. Build that record at the point of care, because rebuilding it after a denial rarely works.

Pro Tip

Run a quarterly J7332 denial report grouped by reason code. If authorization denials dominate, the fix sits in scheduling. If unit or code errors dominate, the fix sits in charge entry and the charge master.

How Pabau keeps J7332 claims and syringe records together

A Triluron series spans three visits, an authorization, and a stack of records. In Pabau, a practice management platform with built-in claims tools, the whole series sits on one patient record.

Pabau’s claims management software submits the J7332 and 20610 lines and tracks each claim’s status. Denial codes come back to the same record, so your team sees which visit needs work.

Visit notes hold the NDC, lot number, dose, and knee for each injection. Checkout then collects the patient’s coinsurance before they leave.

Pabau checkout screen showing a completed payment and an itemized invoice
Pabau’s checkout records the patient’s payment and itemizes the invoice. Collecting the 20% coinsurance at each Triluron visit keeps it out of aging receivables.

Keep every Triluron series on one record

Pabau’s claims management submits your J7332 and 20610 lines and tracks each claim’s status and denial codes. Visit notes, NDCs, and payments sit on the same patient record.

Pabau claims management dashboard

Conclusion

J7332 is a single-product code. It bills Triluron at 1 mg per unit, and one full syringe is 20 units. Most J7332 denials trace back to losing sight of one of those facts.

Match the NDC to the code before each claim, and price the drug from the current ASP file. Confirm authorization before the first injection, not after the third.

Book a demo to see how Pabau keeps a full Triluron series, from authorization to payment, on one record.

Continue your research

Continue your research

Need a foundation in HCPCS drug code billing? Medical billing fundamentals guide covers how Part B drug claims move from charge entry to payment posting.

Want to reduce denials across your practice? Denial management in healthcare explains how to build a denial-tracking and appeal workflow that reduces rework.

Billing Synvisc or Synvisc-One instead? HCPCS code J7325 covers the per-mg units for both the 16 mg and 48 mg products.

Working with a per-dose hyaluronan? HCPCS code J7323 shows how Euflexxa bills one unit per injection.

Frequently asked questions

What does HCPCS Code J7332 cover?

J7332 covers Triluron, a sodium hyaluronate injection for knee osteoarthritis, billed per 1 mg. The descriptor names Triluron only, so other hyaluronan products bill their own codes. The injection itself bills separately, usually with CPT 20610 or 20611.

How many units should be reported for J7332?

One unit equals 1 mg. A full Triluron syringe holds 20 mg, so each injection bills 20 units. Bill each of the three weekly injections on its own date of service, never 60 units on one line.

Does Medicare cover hyaluronic acid knee injections under J7332?

Yes. Medicare Part B covers Triluron under J7332 for knee osteoarthritis, following your contractor’s billing and coding article. Those articles set the covered diagnoses and repeat-series rules. Medicare pays 80% of the ASP plus 6% limit, and the patient owes 20% coinsurance.

Does J7332 require prior authorization?

Traditional Medicare does not require prior authorization for J7332, but Medicare Advantage plans and most commercial insurers do. Requests usually need imaging that supports knee osteoarthritis, records of failed conservative care, and a physician attestation. A missing authorization is a common denial and hard to overturn.

What is the Medicare Part B reimbursement rate for J7332?

Medicare pays J7332 at the average sales price plus 6%. CMS updates that per-unit limit every quarter in the ASP pricing files. Multiply it by 20 to price one syringe. The physician fee schedule search prices the 20610 administration, not the drug.

Avatar photo
Despina Petrushevska
Content Writer

Despina Petrushevska is a content writer covering aesthetics, dermatology, and clinic operations, known for making detailed clinical concepts clear and engaging. Outside of work, she enjoys photography, weekend getaways, and finding inspiration in everyday experiences.
×